# Zhi Gao Holding

> Zhi Gao Holding is a VC fund backing Biotechnology, Pharmaceutical and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Aug 2021
- Lead investor: 0%
- Last updated: Aug 2026

Zhi Gao Holding is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Pharmaceutical | 2 | 67% |
| Health Care | 1 | 33% |
| Therapeutics | 1 | 33% |
| Clinical Trials | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Seed | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xeno Biosciences | Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts. | $7.3M | Series A | Aug 08, 2021 |  |
| Astrocyte Pharmaceuticals | Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $6M | Series A | May 03, 2021 |  |
| Astrocyte Pharmaceuticals | Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. |  | Seed |  |  |

3 of 3 investments shown.

## Co-investors
- [Boston Harbor Angels](https://shizune.co/investors/profile/boston-harbor-angels) — VC Fund, 3 deals together
- [Sidecar Angels](https://shizune.co/investors/profile/sidecar-angels) — VC Fund, 3 deals together
- [CR Ventures](https://shizune.co/investors/profile/cr-ventures) — VC Fund, 2 deals together
- [Mass Medical Angels](https://shizune.co/investors/profile/mass-medical-angels) — VC Fund, 2 deals together
- [Beacon Angels](https://shizune.co/investors/profile/beacon-angels) — VC Fund, 1 deal together
- [Dirigo Angels](https://shizune.co/investors/profile/dirigo-angels) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Zhi Gao Holding invest in?

Zhi Gao Holding invests primarily in Biotechnology, Pharmaceutical and Health Care startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Zhi Gao Holding last invest?

The most recent investment recorded for Zhi Gao Holding closed in Aug 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co